🇺🇸 FDA
Patent

US 6562589

AIB1, a novel steroid receptor co-activator

expired A61KA61K38/00A61P

Quick answer

US patent 6562589 (AIB1, a novel steroid receptor co-activator) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue May 13 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K38/00, A61P, A61P35/04